Dr Anna Nuttall is a highly regarded private and NHS Rheumatologist based in North London, specialising in the diagnosis and management of a wide range of rheumatological conditions. Her expertise includes osteoporosis, hypermobility, gout, inflammatory arthritis, and inflammatory connective tissue diseases such as lupus, myositis, and vasculitis. Dr Nuttall graduated from the prestigious Oxford University and Imperial College London Medical Schools, followed by advanced MD research at University College London.
Currently, Dr Nuttall serves as the clinical lead at the Whittington Hospital, where she oversees rheumatology services, including the provision of biologic medications. She has authored several publications focusing on systemic sclerosis and lupus, as well as contributing a chapter to a rheumatology textbook, showcasing her depth of knowledge and expertise.
Known for her personable and attentive approach, Dr Nuttall prioritises clear communication and building strong relationships with her patients. Fluent in both English and Russian, she is able to connect with a diverse patient population. Dr Nuttall is recognised by all major private insurance providers, making her services accessible to a wide range of patients seeking expert rheumatological care.
Dr Nuttall has a strong interest in rheumatology research and education.
Dr Nuttall is a highly experienced lecturer in rheumatology as well as communication and history taking skills at the prestigious PassPACES postgraduate course for doctors taking specialty MRCP examinations in medicine. She is also an education lead for rheumatology undergraduate medical students from UCL.
A chapter covering the basic science and clinical practice of rheumatology, written for the Oxford University Press postgraduate medical revision series used by doctors training in specialist medicine in the UK.
A comprehensive review focusing on the systemic lupus erythematosus (SLE) assessment tools currently in use and their translational application in clinical research and trials.
A study showing that in systemic sclerosis, epidermal cells are in a persistently activated state and can promote dermal fibrosis, suggesting biologic therapies could target epithelial-fibroblast interactions.
A thesis submitted for the Degree of Doctor of Medicine at University College London exploring the underlying mechanisms and the role of the epidermis in systemic sclerosis.
Delivering comprehensive, patient-centred treatment plans using the latest evidence-based medicine.
Get in Touch TodayDirect Appointments:
Nuffield Health Highgate Hospital
17-19 View Road, Highgate, London, N6 4DJ
Appointments (via PA):
15 Portland Pl, London W1B 1PT
Appointments (via PA):
Golders Green Outpatients & Diagnostic Centre
296 Golders Green Rd, London NW11 9PY